“Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-alpha7 to drive hypoxia-inducible factor (HIF)-1alpha nuclear translocation.”
Tazat, K., S. Schindler, R. Depping and N. J. MabjeeshCytoskeleton (Hoboken), 2018.
Cytoskeleton (Hoboken), 2018.
“The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation.”
Shim, S. M., H. R. Choi, K. W. Sung, Y. J. Lee, S. T. Kim, D. Kim, S. R. Mun, J. Hwang, H. Cha-Molstad, A. Ciechanover, B. Y. Kim and Y. T. KwonSci Signal, 2018.
“The Role of E3, E4 Ubiquitin Ligase (UBE4B) in Human Pathologies.”
Antoniou, N., N. Lagopati, D. I. Balourdas, M. Nikolaou, A. Papalampros, P. V. S. Vasileiou, V. Myrianthopoulos, A. Kotsinas, Y. Shiloh, M. Liontos and V. G. GorgoulisCancers (Basel), 2019.
“beta-TrCP upregulates HIF-1 in prostate cancer cells.”
Cohen, M., S. Amir, M. Golan, Y. Ben-Neriah and N. J. MabjeeshProstate, 2019.
“Monitoring stress-induced autographic engulfment and degradation of the 265 proteasome in Mammalian cells.”
Cohen-Kaplan, V., I. Livneh, Y. T. Kwon and A. CiechanoverMethod in Enzymology, 2019.
“The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break Repair.”
Baranes-Bachar, K., A. Levy-Barda, J. Oehler, D. A. Reid, I. Soria-Bretones, T. C. Voss, D. Chung, Y. Park, C. Liu, J. B. Yoon, W. Li, G. Dellaire, T. Misteli, P. Huertas, E. Rothenberg, K. Ramadan, Y. Ziv and Y. ShilohMol Cell, 2018.
“beta-TrCP upregulates HIF-1 in prostate cancer cells.”
Cohen, M., S. Amir, M. Golan, Y. Ben-Neriah and N. J. MabjeeshProstate, 2018.
“LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.”
Furth, N., I. S. Pateras, R. Rotkopf, V. Vlachou, I. Rivkin, I. Schmitt, D. Bakaev, A. Gershoni, E. Ainbinder, D. Leshkowitz, R. L. Johnson, V. G. Gorgoulis, M. Oren and Y. AylonLife Sci Alliance, 2018.
“UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors.”
Jachimowicz, R. D., F. Beleggia, J. Isensee, B. B. Velpula, J. Goergens, M. A. Bustos, M. A. Doll, A. Shenoy, C. Checa-Rodriguez, J. L. Wiederstein, K. Baranes-Bachar, C. Bartenhagen, F. Hertwig, N. Teper, T. Nishi, A. Schmitt, F. Distelmaier, H. J. Ludecke, B. Albrecht, M. Kruger, B. Schumacher, T. Geiger, D. S. B. Hoon, P. Huertas, M. Fischer, T. Hucho, M. Peifer, Y. Ziv, H. C. Reinhardt, D. Wieczorek and Y. ShilohCell, 2018.
“A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.”
Kotler, E., O. Shani, G. Goldfeld, M. Lotan-Pompan, O. Tarcic, A. Gershoni, T. A. Hopf, D. S. Marks, M. Oren and E. SegalMol Cell, 2018.
“An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.”
Mancini, M., H. Gal, N. Gaborit, L. Mazzeo, D. Romaniello, T. M. Salame, M. Lindzen, G. Mahlknecht, Y. Enuka, D. G. Burton, L. Roth, A. Noronha, I. Marrocco, D. Adreka, R. E. Altstadter, E. Bousquet, J. Downward, A. Maraver, V. Krizhanovsky and Y. YardenEMBO Mol Med, 2018.
“Small Molecules Co-targeting CKIalpha and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.”
Minzel, W., A. Venkatachalam, A. Fink, E. Hung, G. Brachya, I. Burstain, M. Shaham, A. Rivlin, I. Omer, A. Zinger, S. Elias, E. Winter, P. E. Erdman, R. W. Sullivan, L. Fung, F. Mercurio, D. Li, J. Vacca, N. Kaushansky, L. Shlush, M. Oren, R. Levine, E. Pikarsky, I. Snir-Alkalay and Y. Ben-NeriahCell, 2018.
“Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.”
Arandkar, S., N. Furth, Y. Elisha, N. B. Nataraj, H. van der Kuip, Y. Yarden, W. Aulitzky, I. Ulitsky, B. Geiger and M. OrenProc Natl Acad Sci U S A, 2018.
“An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.”
Mancini, M., H. Gal, N. Gaborit, L. Mazzeo, D. Romaniello, T. M. Salame, M. Lindzen, G. Mahlknecht, Y. Enuka, D. G. Burton, L. Roth, A. Noronha, I. Marrocco, D. Adreka, R. E. Altstadter, E. Bousquet, J. Downward, A. Maraver, V. Krizhanovsky and Y. YardenEMBO Mol Med, 2017.
“Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance.”
Morgenstern, Y., U. Das Adhikari, M. Ayyash, E. Elyada, B. Toth, A. Moor, S. Itzkovitz and Y. Ben-NeriahEMBO J, 2017.
“The short and the long: non-coding RNAs and growth factors in cancer progression.”
Sas-Chen, A., S. Srivastava and Y. YardenBiochem Soc Trans, 2017.